FDA Clearance Tracker · P990002-S002
FEMSOFT URETHRAL INSERT
Last checked: Nov 20, 2026Latest source record: Mar 21, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Mar 21, 2013
Approved
Time to decision
85 days
Received Dec 26, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P990002-S002
- Device name
- FEMSOFT URETHRAL INSERT
- Applicant
- Rochester Medical Corp.
- Applicant location
- Stewartville, MN
- Received
- Dec 26, 2012
- Decided
- Mar 21, 2013
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P990002
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR LABELING MODIFICATIONS.
Source documents
Other decisions for Rochester Medical Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.